Navigation Links
Genentech and Novartis Remain Image Leaders in Oncology and Hematology

LIVONIA, Mich., June 2, 2011 /PRNewswire/ -- Genentech and Novartis have the best image among oncologists and hematologists, according to Market Strategies International, a market research consultancy that recently completed its 2011 MSImage study. The study evaluated more than 30 sales force, corporate equity and R&D attributes to determine which measures drive a company's image and performance in this rapidly growing marketplace.

Amgen, Sanofi-aventis and Eli Lilly/ImClone round out the top five among oncologists, and Celgene, Millennium: The Takeda Oncology Company and Amgen round out the top five for hematologists.Rank











Eli Lilly/ImClone

AmgenWhile Genentech maintains a slim lead across office-based and hospital-based oncologists and hematologists, Novartis remains the only other company tied with Genentech for top-tier status.  And, although Genentech slightly extended their lead across several key measures, Novartis is now ranked first by hospital oncologists in the Sales Force dimension and closed the gap on Genentech in the Product/R&D dimension.  

"Last year, Novartis joined Genentech as a top-tier company among office-based oncologists, but now the improvement is mixed. There are specific areas that Novartis needs to improve on if it hopes to claim the top spot from Genentech," said Brock Walter, vice president, Specialty Pharmaceuticals division, Market Strategies International.

Study results indicate that top performers engage in behaviors that are most important to physicians. Specifically, there is a strong correlation between a highly favorable image and behaviors such as a physician's likelihood to:

  • Recommend products to colleagues
  • Make additional time for sales reps and MSLs
  • Try new products'/>"/>

  • SOURCE Market Strategies International
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
    2. Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash
    3. Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation
    4. Roche Completes Tender Offer for Genentech
    5. Agendia Supports Genentechs Citizens Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards
    6. MRC Technology Enters Into an Exclusive License Agreement With Genentech
    7. PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech
    8. Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
    9. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
    10. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
    11. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
    Post Your Comments:
    (Date:10/8/2015)... 2015 .   ... Goldman Small Cap Research, a stock market ... microcap sectors, announced today that it has published ... Inc. (OTCQB - PMCB), a publicly traded, clinical ... treatments for cancer and diabetes. To view the ...
    (Date:10/8/2015)... , Oct. 8, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... company focused on the development of autologous cell therapies, today ... partnering meetings taking place in the month of October: ... Partnering Forum RepliCel will be presenting at the ... on the Mesa to be held October 7-9 in ...
    (Date:10/8/2015)... CA (PRWEB) , ... October 08, 2015 , ... ... mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and results in ... viscous and sticky mucus accumulates in the lungs. This mucus is very difficult ...
    (Date:10/7/2015)... , Oct. 7, 2015  ChromaDex Corp. ... and nutritional ingredients that creates science-based solutions for ... nutrition, and pharmaceutical products, today announced that the ... CEO and Founder, is now available for on-demand ... -->   --> ...
    Breaking Biology Technology:
    ... we get it done. We enact and implement all of ... our economy. Lets paint a picture of what that economy ... a look at the list of what needs to be ... formation, eliminating the death tax, broadband adoption, linking the colleges ...
    ... year, 20 teams will present. Photo courtesy of UW-Madison. ... Wisconsin's biomedical engineering department will have a chance ... on Friday at the Biomedical Engineering Design Expo. , ,Starting ... Engineering Drive, 20 teams of students will present their semester ...
    ... what? Everyone thinks I have some cushy job lined up ... Department of Health and Human Services, but they couldn't be ... federal ethics rules basically keep Cabinet secretaries from talking to ... meant staying inside the Bush administration. The rules make sense, ...
    Cached Biology Technology:
    (Date:9/30/2015)... global glucose monitoring device and diabetes management market is valued ... on the industry from Kalorama Information. Sales in the traditional glucose ... continuous glucose monitoring and sensor segment, according to the healthcare ... in its latest report, The Global Glucose Monitoring Market ... , ...
    (Date:9/28/2015)... NEW YORK , Sept. 28, 2015 /PRNewswire/ ... rate, respiration rate and body temperature, is an ... signs can be indicators of deterioration in a ... the hospital, vital signs are typically taken during ... eight hours. If a patient deteriorates between these ...
    (Date:9/26/2015)... 2015  Results of a TactioRPM pilot project ... at the Stanford Medicine X Conference. In a ... Connected Health Devices and Pharmacogenomics", Roger Simard ... explain how senior patients equipped with connected health ... via the TactioRPM remote patient monitoring platform were ...
    Breaking Biology News(10 mins):
    ... Botanical Garden have described eight new plant species collected in ... eastern slopes of the Andes in northern Bolivia. The new ... published in a recent edition of the Missouri Botanical Garden ... and colleagues from the National Herbarium in La Paz, Bolivia ...
    ... Today, about half the world,s population lives in areas at ... humans through bites from mosquitoes, and each year causes hundreds ... in the United States. The malaria-causing parasite, ... Anopheles mosquito, which feeds on human blood. P. ...
    ... novel diagnostic biomarker for ectopic pregnancy, according to a study ... Clinical Endocrinology & Metabolism ( JCEM ). In ... but in the developing world one in ten women who ... pregnancy is an abnormal pregnancy that occurs outside the uterine ...
    Cached Biology News:
    ... a silica based spin filter membrane to isolate ... DNA band is cut from an agarose gel ... The gel slice is melted irreversibly in a ... bound to the silica spin filter membrane and ...
    ... incorporation of Br-dUTP results in a stronger ... a fluorescein-labeled anti-BrdU antibody. Propidium iodide/RNase ... to counterstain the total DNA. Features and ... improved detection than found by using biotin- ...
    Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
    Biology Products: